Articles Archives - Page 342 of 623

TuesdayFeb 23, 2021 2:09 pm

Gage Cannabis Sets Sights on Becoming Michigan’s Top Cannabis Brand, Concludes Successful Equity Financing Offering

Gage Cannabis recently closed on Regulation A equity financing offering, raising gross proceeds of $50 million Issuance was oversubscribed, resulted in addition of over 1,000 new investors to Gage Cannabis’ shareholder base Gage Cannabis plans to use the proceeds to further expand Gage’s retail reach, pursue M&A opportunities and help solidify the company’s position as one of the leading operators in the state of Michigan Company also announced appointment of Richard Mavrinac to Board of Directors Gage Growth Corp. (d.b.a. Gage Cannabis) (“Gage Cannabis”), a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, recently announced that…

TuesdayFeb 23, 2021 1:55 pm

Friendable Inc. (FDBL) Leveraging Industry Experience For Fan Pass Platform Expansion and Growth

Founders Robert A. Rositano Jr. and Dean Rositano have over 25 years of experience that includes the first-ever Internet IPO and World Wide Web Directory The Rositano brothers released a disruptive social network, nettaxi.com, before Facebook became popular, exiting the industry with approximately a $700 million market cap Fan Pass recently appointed media and digital advertising expert John Haugh as the VP of sales, operations, and business development Friendable Inc. plans to continue expanding and innovating the Fan Pass platform, addressing all artist needs and desires through their platform and Pro Serives Since being founded by entrepreneurial brothers Robert A.…

TuesdayFeb 23, 2021 1:37 pm

InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Makes New Strides in Insurtech Disruption

InsuraGuest renews InsuraGuest Hospitality Liability coverages contract with Wintergreen resort InsuraGuest recently expanded platform integration to about 82 different property management systems connecting with all the big names in the hospitality sector InsureThePeople is integrating innovation and technology to deliver to the U.S small business market InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF) is an insurtech (insurance+technology) company engaged in delivering digital insurance to multiple sectors through its proprietary software platform. The company harnesses the power of technology to deliver insurance digitally across all sectors, empowering clients by offering on-demand insurance products. Insuraguest Technologies recently announced the renewal of its annual…

TuesdayFeb 23, 2021 1:18 pm

HYB Holding Corp. (HYBG) Subsidiary Tech Transforms Ultrasound Images, Improves Patient Diagnosis and Care

With Mediscan, the option of having scanning equipment at patient’s location is becoming increasingly viable Patent-pending Mediscan software converts ultrasound analog 2D grayscale image into digital 3D HD format Software can generate quality 3D medical images of broad variety of organs, including heart, lungs, tendons, skin and nerves Since its introduction into the world of medicine, the ultrasound has become one of the most efficient, reliable ways to examine the human body in a noninvasive way. And now, this medical mainstay has become even more essential in providing quality care — proprietary technology from HYB Holding (OTC: HYBG) subsidiary Mediscan Inc.…

MondayFeb 22, 2021 3:22 pm

Knightscope Inc.’s Security Robots Are Cost Effective

Knightscope, Inc. designs, engineers, builds, deploys, and services autonomous data machines (“ADMs”) also known as security robots It currently offers three operational robots in the U.S.: K1 Stationary, K3 Indoors, and K5 Outdoors The robots are cheaper for clients per hour compared to human guards and run 24/7 Knightscope charges between $4 and $11 per hour for its machines on annual contracts, while security companies can charge between $15 and $35 an hour for an unarmed guard and about $85 per hour for an armed guard, according to Knightscope’s CEO Investors can purchase shares in Knightscope through its Reg A+…

MondayFeb 22, 2021 12:43 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industry The company intends to use its test tech partnership with Germany’s 3a-diagnostics GmbH to build additional bacteriological and viral testing products A separate subsidiary based in Alberta is developing psychedelic medicine programs The subsidiary recently announced it has added mescaline production to…

MondayFeb 22, 2021 12:10 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) Closer to Pure Mushrooms Sales with Company Code, NPN Submission

PULL recently received Company Code from Canada’s Natural and Non-prescription Health Products Directorate Code allows PULL to submit application to sell its first functional mushroom product Company intends to submit additional NPN applications during 2021 as part of larger strategy to develop portfolio of functional mushroom wellness products Functional mushrooms, those that provide a health benefit beyond just nutrition, are growing in popularity worldwide amid an accelerating trend to fend off viruses with immune-boosting food and drinks. Looking to seize part of a global functional mushroom market forecast by Data Bridge Market Research to hit $555.9 billion by 2028, Pure…

MondayFeb 22, 2021 11:56 am

Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech

Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offering The closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is granted With better viewing options, the technology is designed to make it easier for surgeons to detect the full parameters of bladder tumors and remove them more completely Bladder cancer is one of the most prevalent cancers in the United States, particularly in men The technological improvement of these surgical procedures can provide an attractive…

MondayFeb 22, 2021 11:40 am

PowerTap, an Investee Company of Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Announces USA Hydrogen Station Distribution Model

PowerTap Hydrogen Fueling has signed a definitive agreement with the Andretti Group to create an optimized network by leveraging the latter’s operational expertise and global reach PowerTap plans to have 500 operational hydrogen filling stations deployed across the country by the end of 2025 The existing business model's deployment of hydrogen stations expedites rollout due to the existing fuel operations on each site The hydrogen fuel cell vehicle market worldwide was valued at $651.9 million in 2018 and is expected to grow to over $42 billion by 2026 Stemming from the announcement made by Clean Power Capital (CSE: MOVE) (FWB:…

MondayFeb 22, 2021 10:29 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Alternatives to Current Standard of Care for Anxiety Disorders

American Psychiatric Association poll reveals 62% of respondents have anxiety about COVID-19 Recent FDA Drug Safety Communication requires updated Boxed Warning for benzodiazepines commonly used to treat anxiety disorders VTGN is committed to developing and commercializing PH94B, a first-in-class pherine nasal spray with potential to go beyond the current standard of care for acute treatment of social anxiety disorder and other anxiety-related disorders Anxiety induced by the COVID-19 pandemic during the last year has been linked with surging use of benzodiazepines or “benzos,” a drug class commonly prescribed to treat anxiety and other disorders - a trend with potential to…

Site Search

Company Search

Category: Articles